Unified Medical Language System (UMLS). Medical Subject Headings (MeSH)

Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3-((4-fluorophenyl)methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6,7-dihydroxy-4-(4-morpholinylmethyl)-2H-1-benzopyran-2-one hydrochloride and 2-methyl-2-propyl-1,3-propanediyl dicarbamate (MeSH)

Search & browse in old database A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3-((4-fluorophenyl)methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6,7-dihydroxy-4-(4-morpholinylmethyl)-2H-1-benzopyran-2-one hydrochloride and 2-methyl-2-propyl-1,3-propanediyl dicarbamate (MeSH) - C0057573 L0158900 S0217023 A0239273 M0040857 MeSH N1 C000884 doctor.am